
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.
Subscribe to Eagle’s Eye View
4.7
127127 ratings
In this week’s View, Dr. Eagle explores the role of inflammation as a predictor of coronary risk. He then discusses the safety and efficacy of renal denervation in patients taking antihypertensive medications. Finally, Dr. Eagle examines amiodarone and pulmonary toxicity in atrial fibrillation.
Subscribe to Eagle’s Eye View
130 Listeners
325 Listeners
159 Listeners
865 Listeners
492 Listeners
32 Listeners
279 Listeners
87 Listeners
1,086 Listeners
60 Listeners
39 Listeners
185 Listeners
348 Listeners
423 Listeners
35 Listeners